An in-vivo and in-vitro taste masking evaluation of bitter melt-extruded drugs

Journal of Pharmacy and Pharmacology

Volumn 66, Issue 2, 2014, Pages 323-337

  Maniruzzaman, Mohammed ^a   Bonnefille, Marion ^b   Aranyos, Attila ^b   Snowden, Martin J ^a   Douroumis, Dennis ^a  

^a UNIVERSITY OF GREENWICH   (United Kingdom)

^b Alpha MOS   (France)

Author keywords

e tongue; hot melt extrusion; molecular dispersions; taste masking

Indexed keywords

CETIRIZINE; EUDRAGIT; PLACEBO; VERAPAMIL;

ADULT; ARTICLE; BITTER TASTE; CONTROLLED STUDY; DRUG FORMULATION; DRUG MANUFACTURE; DRUG MIXTURE; DRUG RELEASE; DRUG SCREENING; FEMALE; HOT MELT EXTRUSION; HUMAN; HUMAN EXPERIMENT; IN VITRO STUDY; IN VIVO STUDY; LABORATORY DEVICE; MALE; NORMAL HUMAN; PROCESS OPTIMIZATION; SCREW EXTRUDER; YOUNG ADULT;

E-TONGUE; HOT-MELT EXTRUSION; MOLECULAR DISPERSIONS; TASTE MASKING;

ACRYLIC RESINS; ADOLESCENT; ADULT; CETIRIZINE; DRUG CARRIERS; DRUG COMPOUNDING; DRUG STABILITY; FEMALE; FREEZING; HOT TEMPERATURE; HUMANS; MALE; PATIENT COMPLIANCE; POLYMETHACRYLIC ACIDS; SOLUBILITY; TASTE; VERAPAMIL; YOUNG ADULT;

EID: 84892691593     PISSN: 00223573     EISSN: 20427158     Source Type: Journal    
DOI: 10.1111/jphp.12169     Document Type: Article

References (32)

1. Maniruzzaman M, et al. Taste masking of paracetamol by hot-melt extrusion: an in vitro and in vivo evaluation. Eur J Pharm Biopharm 2012; 80: 433-442.
2. Gryczke A, et al. Development and evaluation of orally disintegrating tablets (ODTs) containing ibuprofen granules prepared by hot melt extrusion. Colloids Surf B Biointerfaces 2011; 86: 275-284.
3. Ayenew Z, et al. Trends in pharmaceutical taste masking technologies: a patent review. Recent Pat Drug Deliv Formul 2009; 3: 26-39.
4. Douroumis DD, et al. Development and evaluation of cetirizine HCl taste-masked oral disintegrating tablets. AAPS PharmSciTech 2011; 12: 141-151.
5. Al-Omran MF, et al. Taste masking of diclofenac sodium using microencapsulation. J Microencapsul 2002; 19: 45-52.
6. Shah PP, et al. Design and optimization of mefloquine hydrochloride microparticles for bitter taste masking. AAPS PharmSciTech 2008; 9: 377-389.
7. Albertini B, et al. Characterization and taste-masking evaluation of acetaminophen granules: comparison between different preparation methods in a high-shear mixer. Eur J Pharm Sci 2004; 21: 295-303.
8. Benoit JP, et al. Method of coating particles and coated spherical particles. US Patent 2000; 6: 1-27.
9. Mazen H, York P,. Particle formation methods and their products. US Patent 2006; 7: 1-67.
10. Bora D, et al. Taste masking by spray-drying technique. AAPS PharmSciTech 2008; 9: 1159-1164.
11. Ono N, et al. Reduction of bitterness of antihistaminic drugs by complexation with ß-cyclodextrins. J Pharm Sci 2010; 100: 1935-1943.
12. Woertz K, et al. Rational development of taste masked oral liquids guided by an electronic tongue. Int J Pharm 2010; 400: 114-123.
13. Suthar AM, Pate MM,. Formulation and evaluation of taste masked suspension of metronidazole. Int J Appl Pharm 2011; 3: 16-19.
14. Menegon RF, et al. A nonstaining and tasteless hydrophobic salt of chlorhexidine. J Pharm Sci 2011; 100: 3130-3138.
15. Michalk A, et al. Controlled release of active as a consequence of the die diameter in solid lipid extrusion. J Control Release 2008; 132: 35-41.
16. Maniruzzaman M, et al. A review on the taste masking of bitter APIs: hot-melt extrusion (HME) evaluation. Drug Dev Ind Pharm 2013; doi: 10.3109/03639045.2013.804833.
17. Woertz K, et al. Taste sensing systems (electronic tongues) for pharmaceutical applications. Int J Pharm 2011; 417: 256-271.
18. Woertz K, et al. Performance qualification of an electronic tongue based on ICH guideline Q2. J Pharm Biomed Anal 2010; 51: 497-506.
19. Woertz K, et al. A comparative study on two electronic tongues for pharmaceutical formulation development. J Pharm Biomed Anal 2011; 55: 272-281.
20. Hansen CM,. The universality of the solubility parameter. Ind Eng Chem Prod Res Dev 1969; 8: 2-11.
21. Hoftyzer PJ, Van Krevelen DW,. Properties of Polymers. Amsterdam: Elsevier, 1976.
22. Bagley EB, et al. Three-dimensional solubility parameters and their relationship to internal pressure measurements in polar and hydrogen bonding solvents. J Paint Technol 1971; 43: 35-42.
23. Jones DS,. Pharmaceutical Statistics. London, UK: The Pharmaceutical Press, 2002.
24. Maniruzzaman M, et al. Dissolution enhancement of poorly water-soluble APIs processed by hot-melt extrusion using hydrophilic polymers. Drug Dev Ind Pharm 2013; 39: 218-227.
25. Maniruzzaman M, et al. Drug-polymer intermolecular interactions in hot-melt extruded solid dispersions. Int J Pharm 2013; 443: 199-208.
26. Greenhalgh DJ, et al. Solubility parameters as predictors of miscibility in solid dispersions. J Pharm Sci 1999; 88: 1182-1190.
27. Breitkreutz J,. Prediction of intestinal drug absorption properties by three dimensional solubility parameters. Pharm Res 1998; 15: 1370-1375.
28. Albers J,. Hot-Melt Extrusion with Poorly Soluble Drugs. Dusseldorf: Heinrich-Heine-Universitat, 2008.
29. Forster A, et al. Selection of excipients for melt extrusion with two poorly water-soluble drugs by solubility parameter calculation and thermal analysis. Int J Pharm 2001; 226: 147-161.
30. Zheng X, et al. Part I: characterization of solid dispersions of nimodipine prepared by hot-melt extrusion. Drug Dev Ind Pharm 2007; 33: 791-802.
31. Abu-Diak OA, et al. An investigation into the dissolution properties of celecoxib melt extrudates: understanding the role of polymer type and concentration in stabilizing supersaturated drug concentrations. Mol Pharm 2011; 8: 1362-1367.
32. Gryczke A,. Innovative Formulations by Melt Extrusion with EUDRAGIT® Polymers. Darmstadt: RÖHM GmbH & Co. KG, 2005.